MALAT1 and urinary bladder cancer: Furthermore, SPRY4-IT1 (Zhao X. L. et al., 2015), MALAT1 (Li et al., 2017), linc-UBC1 (He et al., 2013), lncRNA-LET (Zhuang et al., 2017), ZEB2-AS1 (Wu et al., 2017), XIST (Hu Y. Y. et al., 2017), PVT1 (Cui et al., 2017), and SNHG16 (Cao et al., 2017) were significantly associated with lymph node metastasis status in patients with bladder cancer.